More recently, several pathways have been shown to mediate cancer–bone crosstalk, including Notch33, transforming growth factor-β (ref. 34), HIF35, 36, Integrin37, Irf7 (ref. 38), VCAM1 (ref. 39) and mTOR13. This evidence concerns the gene IRF7 and cancer.